Quarterly report pursuant to Section 13 or 15(d)

Stock Based Compensation Arrangements (Tables)

v3.7.0.1
Stock Based Compensation Arrangements (Tables)
6 Months Ended
Apr. 30, 2017
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

The fair value of each option grant is estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted-average assumptions for the six months ended April 30, 2017:

 

Risk free annual interest rate     1.78-2.28 %
Expected volatility     71.65-86.34 %
Expected life     5.04-6.00  
Assumed dividends   None  

Schedule of Share-based Compensation, Restricted Stock Activity

A summary of the Company’s restricted stock activity in the six months ended April 30, 2017 is presented below:

 

   

Number of

shares

    Weighted-Average Grant-Date Fair Value  
Unvested - October 31, 2016     274,829     $ 6.00  
Granted     1,031,000     $ 4.56  
Vested     (925,488 )   $ 4.00  
Unvested - April 30, 2017     380,341     $ 6.97  

Employee Stock Option [Member]  
Schedule of Share-based Compensation, Stock Options, Activity

A summary of the Company’s employee stock option activity in the six months ended April 30, 2017 is presented below:

 

   

Number of

shares

   

Weighted-Average

Exercise Price

 
Outstanding - October 31, 2016     383,210     $ 5.74  
Granted     2,715,000     $ 3.49  
Exercised     (121,698 )   $ 4.83  
Outstanding - April 30, 2017     2,976,512     $ 3.72  
Options exercisable - April 30, 2017     767,342     $ 4.19  
Weighted-average fair value of options granted during the period           $ 2.37  

Non-Employee Stock Option [Member]  
Schedule of Share-based Compensation, Stock Options, Activity

A summary of the Company’s non-employee stock option activity in the six months ended April 30, 2017 is presented below:

 

   

Number of

shares

   

Weighted-Average

Exercise Price

 
Outstanding - October 31, 2016     -     $ -  
Granted     52,000     $ 4.71  
Outstanding - April 30, 2017     52,000     $ 4.71  
Options exercisable - April 30, 2017     4,333     $ 4.71